Gamboa N Castaño (Natalia Castano, Natalia Castaño, Natalia Castaño-Gamboa)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Atrial Fibrillation

Patient Reported Outcomes

Rheumatoid Arthritis Patients

Klebsiella Pneumoniae

Top Venues

Cost effectiveness and resource allocation : C/E

Health science reports

Expert review of pharmacoeconomics & outcomes research

Vascular health and risk management

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriel Fernando Torres, Brigitte Alejandra Alarcón, Juan Manuel Reyes-Sanchez, Gamboa N Castaño, Giancarlo Buitrago
Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Gabriel Fernando Torres, Brigitte Alejandra Alarcón, Juan Manuel Reyes-Sanchez, Gamboa N Castaño, Giancarlo Buitrago
Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Juan Manuel Reyes-Sanchez, Magda V Gutierrez-Ardila, Hugo Madariaga, William Otero, Renato Guzman, Jorge Izquierdo, David J Del Castillo, Mauricio Abello, Patricia Velez, Dario Ponce de Leon, Tatjana Lukic, Luisa F Amador, Gamboa N Castaño
Impact of access to treatment on patient-reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin-American countries: A prospective observational study. Health science reports 6 (3) (2023)
Juan Manuel Reyes-Sanchez, Magda V Gutierrez-Ardila, Hugo Madariaga, William Otero, Renato Guzman, Jorge Izquierdo, David J Del Castillo, Mauricio Abello, Patricia Velez, Dario Ponce de Leon, Tatjana Lukic, Luisa F Amador, Gamboa N Castaño
Impact of access to treatment on patient-reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin-American countries: A prospective observational study. Health science reports 6 (3) (2023)
Manuel Enrique Machado-Duque, Andrés Gaviria-Mendoza, Juan Manuel Reyes-Sanchez, Alejandro Mesa, Gamboa N Castaño, Luis Fernando Valladales-Restrepo, Jorge Enrique Machado-Alba
Clinical Characteristics, Patterns of Use, and incidence of Adverse Events in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants in Colombia. Vascular health and risk management 19 (2023)
Jorge Enrique Machado-Alba, Juan David Wilches-Gutierrez, Diana Rocio Arias-Osorio, Juan Manuel Reyes-Sanchez, Maria Lourdes Nakandakari, Harrison David Ospina-Arzuaga, Andres Gaviria-Mendoza, Gamboa N Castaño, Luis Fernando Valladales-Restrepo, Manuel E Machado-Duque
The frequency of complications in a cohort of patients diagnosed with hemophilia A and hemophilia B receiving prophylactic treatment in Colombia: A retrospective noninterventional study. PloS one 18 (11) (2023)
Fabio Gil, Fabian Juliao-Baños, Luisa Amador, Gamboa N Castaño, Juan Manuel Reyes-Sanchez
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia. PharmacoEconomics - open 6 (6) (2022)
Juan Manuel Reyes-Sanchez, Jorge LaRotta, Gamboa N Castaño, Mark A Fletcher, Matthew Wasserman, Johnna E Perdrizet, Rodrigo Sini de Almeida
Letter to the editor regarding "Budget impact analysis of pneumococcal conjugate vaccines in Colombia". Expert review of pharmacoeconomics & outcomes research (2021)
F A Varón-Vega, E Lemos, Gamboa N Castaño, Juan Manuel Reyes-Sanchez
Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant Klebsiella pneumoniae in Colombia. Expert review of pharmacoeconomics & outcomes research (2021)